Trial intelligence / Profile preview

Ontaril for Complex Perianal Fistulas in Crohn's Disease

NCT01378390Phase 3Terminated

Sponsor
TiGenix
Start
Dec 2008
Primary completion
Feb 2010
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of CX401 in perianal fistula, sponsored by TiGenix. Started Dec 2008; status: terminated.

02

Drugs

CX401
03

Conditions

perianal fistula

Beyond the preview

Go deeper on NCT01378390.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01378390.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call